ICU Girisim Sermayesi Yatirim Ortakligi A.S.
BBIST:ICUGS1.18
TRY
+0.10
(+9.26%)
ISIN
TRAVKFRS91Q0
Return %
Stock
S&P 500
1Y
-64.56
14.20
3Y
-28.05
81.12
5Y
220.65
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- CEO
- Haci Bayram Basaran
- Sector
- Finance
- Industry
- Investment managers
- Address
- Bayrakli Turkey
- IPO Date
- Jul 5, 2000
- Website
- rheagirisim.com
- Similar Companies
- Business
- ICU Girisim Sermayesi Yatirim Ortakligi A.S. is a Turkey-based venture capital investment trust engaged in providing equity financing, venture capital, and strategic management support to high-growth potential companies and micro-, small-, and medium-sized enterprises (MSMEs). Founded in 1996 and headquartered in Izmir, Turkey, the company operates under Capital Markets Board of Turkey (CMB) regulations as a publicly traded closed-end fund listed on Borsa Istanbul under the ticker ICUGS. The company offers a comprehensive range of investment, financing, and corporate development solutions, including direct equity investments; minority and majority stake acquisitions; mezzanine financing and hybrid debt-equity capital; project financing; seed, early-stage, and growth capital funding; corporate governance and strategic management consulting; operational restructuring and financial advisory; business development and market expansion support; pre-initial public offering (pre-IPO) preparation; and structured exit execution through secondary buyouts, trade sales, and public listings. ICU Girisim focuses its investment activities across sectors such as medical devices and healthcare, battery management and energy storage, clean technology and environmental recycling, software, and financial technology. Its portfolio assets include Seta Tibbi Cihazlar Ithalat ve Ihracat Pazarlama Ticaret ve Sanayi A.S. in medical equipment; Batkon Batarya Kontrol Teknolojileri A.S. in battery control technologies; Netsafe Teknolojik Yatirimlar A.S. in technology ventures; Laska Teknoloji A.S. in sustainable energy and circular economy solutions; and OEP Turkey Tech B.V. In recent developments, the company executed a major corporate rebranding and reorganization, officially changing its commercial title from Rhea Girisim Sermayesi Yatirim Ortakligi A.S. to ICU Girisim Sermayesi Yatirim Ortakligi A.S. to reflect a renewed strategic focus on advanced technology, energy transition, and healthcare ventures. As part of an ongoing portfolio rationalization and capital optimization initiative, the board of directors authorized management to initiate negotiations for the strategic divestment of select holdings, including Netsafe Teknolojik Yatirimlar A.S. and Laska Teknoloji A.S. Concurrently, the firm expanded its technology ecosystem exposure through fintech partnerships and investments such as Plodsi Finansal Teknolojiler and Angel Effect platform participation, while portfolio firm Batkon secured patent registrations and pursued commercial supply agreements within the energy distribution sector.